Erythropoietin Injection

• Type: Hematopoietic growth factor

• Drug Class: Recombinant human erythropoietin (EPO)

• Form: Sterile solution for subcutaneous (SC) or intravenous (IV) injection

How It Works

• Erythropoietin is a hormone normally produced by the kidneys, which stimulates the bone marrow to make red blood cells (RBCs).

• The injection contains a synthetic version of this hormone.

• It binds to erythropoietin receptors in the bone marrow, triggering increased RBC production, improving oxygen-carrying capacity of blood.

Common Uses

Erythropoietin injection is used to treat anemia caused by:

• Chronic kidney disease (CKD) – especially in patients on dialysis

• Chemotherapy-induced anemia in cancer patients

• Anemia related to HIV treatment (zidovudine therapy)

• Pre-operative use (in select cases) to reduce the need for blood transfusion

Advantages

• Reduces the need for blood transfusions

• Improves hemoglobin levels, reducing fatigue and weakness caused by anemia

• Can improve quality of life in patients with chronic illness

Possible Side Effects

Common:

• Headache

• Injection site pain or redness

• Mild flu-like symptoms

Serious but Less Common:

• High blood pressure (most common serious effect)

• Blood clots (DVT, pulmonary embolism, stroke risk increases if hemoglobin is raised too high)

• Pure red cell aplasia (very rare immune reaction causing severe anemia)

Precautions

• Hemoglobin levels should be monitored regularly – target is usually 10–12 g/dL, not higher (to avoid clot risk)

• Use cautiously in patients with uncontrolled hypertension

• Should not be used for performance enhancement (illegal in sports)

• Dose adjustment needed in kidney disease and chemotherapy patients

• Iron status should be checked – often combined with iron supplementation for maximum effect